Silver-coated endotracheal tube dramatically reduces resistant infections

May 19, 2008

A silver-coated endotracheal tube may reduce infections with highly resistant bacteria over traditional tubes by nearly half, according to the results of a large randomized trial to be presented at the American Thoracic Society’s 2008 International Conference in Toronto on Monday, May 19.

Patients who are on ventilators are often at risk for developing ventilator-associated pneumonia (VAP) because of resistant bacteria.

“VAP is a serious disease with significant mortality,” said lead investigator, Andrew Shorr, M.D., M.P.H., of Washington Hospital Center in Washington, D.C. “Crude mortality rates from VAP approach 25 to 30 percent and VAP rates are now thought to reflect hospital quality. These infections include highly resistant pathogens, such as methicillin-resistant Staphylococcus aureus or MRSA, which are the most troubling ones and often the hardest to treat. The average costs associated with treatment of VAP exceed $40,000 because of the impact on length of stay in the ICU.”

To test the efficacy of the silver-coated tube in preventing infections, the study included a modified intention-to-treat population of 1,509 subjects, balanced between traditional endotracheal tubes and the silver coated ones. The researchers used brochoavelolar lavage fluid cultures to ascertain the presence of pathogenic organisms and classified as “highly resistant” organisms MRSA, Pseudomonas aeruginosa (PA) and Acinetobacter bumanii (AB).

They found that VAP in all its forms was reduced by nearly 40 percent in the population with the silver-coated endotracheal tubes and that highly resistant infections were less than half as likely to occur in those with the silver-coated tubes.

“What we show in this present analysis is that the silver-coated breathing tube prevents infections due to the most highly resistant pathogens. Other prevention strategies for VAP have not always been shown to impact the rates of infection with these highly resistant strains,” said Dr. Shorr. “Given the importance of MRSA, PA and AB in the ICU, utilization of the silver-coated endotracheal tube may help contain the spread of antimicrobial resistance.”

Source: American Thoracic Society

Explore further: Were clinical trial practices in East Germany questionable?

add to favorites email to friend print save as pdf

Related Stories

Microsoft beefs up security protection in Windows 10

3 hours ago

What Microsoft users in business care deeply about—-a system architecture that supports efforts to get their work done efficiently; a work-centric menu to quickly access projects rather than weather readings ...

US official: Auto safety agency under review

16 hours ago

Transportation officials are reviewing the "safety culture" of the U.S. agency that oversees auto recalls, a senior Obama administration official said Friday. The National Highway Traffic Safety Administration has been criticized ...

Out-of-patience investors sell off Amazon

16 hours ago

Amazon has long acted like an ideal customer on its own website: a freewheeling big spender with no worries about balancing a checkbook. Investors confident in founder and CEO Jeff Bezos' invest-and-expand ...

Ebola.com domain sold for big payout

16 hours ago

The owners of the website Ebola.com have scored a big payday with the outbreak of the epidemic, selling the domain for more than $200,000 in cash and stock.

Recommended for you

Were clinical trial practices in East Germany questionable?

Oct 23, 2014

Clinical trials carried out in the former East Germany in the second half of the 20th century were not always with the full knowledge or understanding of participants with some questionable practices taking place, according ...

Schumacher's doctor sees progress after injury

Oct 23, 2014

A French physician who treated Michael Schumacher for nearly six months after the Formula One champion struck his head in a ski accident says he is no longer in a coma and predicted a possible recovery within three years.

User comments : 0